Usa India hospital covid-19 testing patient Coronavirus Usa India

Gilead begins testing inhalable form of remdesivir for COVID-19

Reading now: 597
www.livemint.com

Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals.The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization.

The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals.Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized.Gilead is hoping to target the disease at the onset.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA